Related Experiment Video

Updated: May 28, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.5K

MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and Therapeutics

Nikhita Kathuria-Prakash1, Pranali Dave2, Lizette Garcia3

  • 1Division of Hematology/Oncology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.

International Journal of Molecular Sciences
|September 14, 2024
PubMed

Insights

MicroRNAs (miRNAs) show promise for diagnosing and treating genitourinary (GU) cancers. Research is exploring their role as biomarkers for personalized cancer therapy and treatment response.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Genitourinary (GU) cancers represent a significant global health burden.
  • Despite recent advances, improved management strategies for GU malignancies are needed.
  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer development.

Purpose of the Study:

  • To review the current applications of miRNAs in genitourinary (GU) malignancies.
  • To explore the potential of miRNAs as diagnostics, therapeutics, and response biomarkers.
  • To highlight miRNAs as a novel frontier in personalized cancer therapy.

Main Methods:

  • Literature review of preclinical and clinical studies on miRNAs in GU cancers.
  • Analysis of miRNA roles in carcinogenesis and gene expression regulation.
  • Synthesis of current research on miRNA-based diagnostics and therapeutics.

Main Results:

  • MicroRNAs (miRNAs) are involved in the pathogenesis of various GU malignancies.
  • miRNAs demonstrate potential as diagnostic and prognostic biomarkers.
  • Emerging evidence supports the therapeutic application of miRNAs in GU cancer treatment.

Conclusions:

  • MicroRNAs offer a promising avenue for personalized medicine in GU oncology.
  • Further research is warranted to translate miRNA potential into clinical practice.
  • miRNAs represent a novel frontier for GU cancer diagnostics and therapeutics.
Keywords:
MicroRNAadrenocortical cancergenitourinary cancerskidney cancerprostate cancertesticular cancerurothelial cancer

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...